Terms: = Cervical cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE
56 results:
1. [Preparation and identification of rabbit anti-cyclin dependent kinase 6 (cdk6) antibodies].
Ye X; Dong H; Wang Y; Chen Z; Li J; Wei Y; Zhang L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Aug; 39(8):742-747. PubMed ID: 37515341
[TBL] [Abstract] [Full Text] [Related]
2. Serum expression of tumor marker CA242 in patients with different gynecological diseases.
Zhu J; Li H
Lab Med; 2023 Nov; 54(6):613-617. PubMed ID: 37035887
[TBL] [Abstract] [Full Text] [Related]
3. Cytological features of mesonephric-like adenocarcinoma of the uterine corpus.
Seo Y; Park E; Kim HS
Diagn Cytopathol; 2023 May; 51(5):294-306. PubMed ID: 36756667
[TBL] [Abstract] [Full Text] [Related]
4. Chlamydia trachomatis infection co-operatively enhances HPV E6-E7 oncogenes mediated tumorigenesis and immunosuppression.
Challagundla N; Chrisophe-Bourdon J; Agrawal-Rajput R
Microb Pathog; 2023 Feb; 175():105929. PubMed ID: 36565970
[TBL] [Abstract] [Full Text] [Related]
5. A review on the role of PCGEM1 lncRNA in cancer.
Ghafouri-Fard S; Khoshbakht T; Hussen BM; Baniahmad A; Taheri M; Mokhtari M
Pathol Res Pract; 2022 Dec; 240():154223. PubMed ID: 36403313
[TBL] [Abstract] [Full Text] [Related]
6. [Results of laparoscopic pelvic exenterations].
Sanzharov AE; Gallyamov EA; Sergeev VP; Biktimirov RG; Aminova LN; Kochkin AD; Meshchankin IV; Agapov MA; Gololobov GY
Khirurgiia (Mosk); 2022; (7):45-57. PubMed ID: 35775844
[TBL] [Abstract] [Full Text] [Related]
7. Gamma-Glutamyltransferase Activity (GGT) Is a Long-Sought Biomarker of Redox Status in Blood Circulation: A Retrospective Clinical Study of 44 Types of Human Diseases.
Bai C; Zhang M; Zhang Y; He Y; Dou H; Wang Z; Wang Z; Li Z; Zhang L
Oxid Med Cell Longev; 2022; 2022():8494076. PubMed ID: 35707277
[TBL] [Abstract] [Full Text] [Related]
8. Significant growth inhibition by a bispecific affibody targeting oncoprotein E7 in both HPV16 and 18 positive cervical cancer in vitro and in vivo.
Tan X; Yang J; Jiang J; Wang W; Ren J; Li Q; Xie Z; Chen X; Zhang L; Li W
Eur J Pharm Sci; 2022 May; 172():106156. PubMed ID: 35245683
[TBL] [Abstract] [Full Text] [Related]
9. cdk6 increases glycolysis and suppresses autophagy by mTORC1-HK2 pathway activation in cervical cancer cells.
Zhang X; Sun Y; Cheng S; Yao Y; Hua X; Shi Y; Jin X; Pan J; Hu MG; Ying P; Hou X; Xia D
Cell Cycle; 2022 May; 21(9):984-1002. PubMed ID: 35167417
[TBL] [Abstract] [Full Text] [Related]
10. Circular RNA cdk6 suppresses cervical cancer proliferation and metastasis by sponging miR-449a.
Zhong P; Guo A; Wang L; Lin X; Feng M
Bioengineered; 2022 Mar; 13(3):4885-4897. PubMed ID: 35152839
[TBL] [Abstract] [Full Text] [Related]
11. Downregulation of NCL attenuates tumor formation and growth in HeLa cells by targeting the PI3K/AKT pathway.
Ying J; Pan R; Tang Z; Zhu J; Ren P; Lou Y; Zhang E; Huang D; Hu P; Li D; Bao Q; Li P
Cancer Med; 2022 Mar; 11(6):1454-1464. PubMed ID: 35128835
[TBL] [Abstract] [Full Text] [Related]
12. A meta-analysis of survival after minimally invasive radical hysterectomy versus abdominal radical hysterectomy in cervical cancer: center-associated factors matter.
Sun S; Cai J; Li R; Wang Y; Zhao J; Huang Y; Xu L; Yang Q; Wang Z
Arch Gynecol Obstet; 2022 Sep; 306(3):623-637. PubMed ID: 35061066
[TBL] [Abstract] [Full Text] [Related]
13. EphA2 promotes tumorigenicity of cervical cancer by up-regulating cdk6.
Huang C; Chen Z; He Y; He Z; Ban Z; Zhu Y; Ding L; Yang C; Jeong JH; Yuan W; Yang L
J Cell Mol Med; 2021 Mar; 25(6):2967-2975. PubMed ID: 33586348
[TBL] [Abstract] [Full Text] [Related]
14. Cyclin Pathway Genomic Alterations Across 190,247 Solid Tumors: Leveraging Large-Scale Data to Inform Therapeutic Directions.
Jardim DL; Millis SZ; Ross JS; Woo MS; Ali SM; Kurzrock R
Oncologist; 2021 Jan; 26(1):e78-e89. PubMed ID: 32885893
[TBL] [Abstract] [Full Text] [Related]
15. Synchronization of human retinal pigment epithelial-1 cells in mitosis.
Scott SJ; Suvarna KS; D'Avino PP
J Cell Sci; 2020 Sep; 133(18):. PubMed ID: 32878943
[TBL] [Abstract] [Full Text] [Related]
16. miR-636 represses cell survival by targeting cdk6/Bcl-2 in cervical cancer.
Hu QL; Xu ZP; Lan YF; Li B
Kaohsiung J Med Sci; 2020 May; 36(5):328-335. PubMed ID: 31889428
[TBL] [Abstract] [Full Text] [Related]
17. Synergistic anti-tumor effect of paclitaxel and miR-34a combined with ultrasound microbubbles on cervical cancer in vivo and in vitro.
Yu J; Zhao Y; Liu C; Hu B; Zhao M; Ma Y; Jiang J
Clin Transl Oncol; 2020 Jan; 22(1):60-69. PubMed ID: 31093891
[TBL] [Abstract] [Full Text] [Related]
18. cdk6 3'UTR polymorphisms alter the susceptibility to cervical cancer among Uyghur females.
Aierken K; Dong Z; Abulimiti T; Zhang Y; Abuduxikuer G; Tuerxun G; Abudurexiti G; Maimaitiaishan A; Mijiti P; Abulizi G
Mol Genet Genomic Med; 2019 May; 7(5):e626. PubMed ID: 30829464
[TBL] [Abstract] [Full Text] [Related]
19. Ribociclib, a selective cyclin D kinase 4/6 inhibitor, inhibits proliferation and induces apoptosis of human cervical cancer in vitro and in vivo.
Xiong Y; Li T; Assani G; Ling H; Zhou Q; Zeng Y; Zhou F; Zhou Y
Biomed Pharmacother; 2019 Apr; 112():108602. PubMed ID: 30784916
[TBL] [Abstract] [Full Text] [Related]
20. Down-regulation of long non-coding RNA ANRIL inhibits the proliferation, migration and invasion of cervical cancer cells.
Zhang WY; Liu YJ; He Y; Chen P
Cancer Biomark; 2018; 23(2):243-253. PubMed ID: 30198868
[TBL] [Abstract] [Full Text] [Related]
[Next]
